These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10593428)

  • 1. Effect of cilostazol, a phosphodiesterase III inhibitor, on experimental thrombosis in the porcine carotid artery.
    Kohda N; Tani T; Nakayama S; Adachi T; Marukawa K; Ito R; Ishida K; Matsumoto Y; Kimura Y
    Thromb Res; 1999 Nov; 96(4):261-8. PubMed ID: 10593428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cilostazol inhibits leukocyte integrin Mac-1, leading to a potential reduction in restenosis after coronary stent implantation.
    Inoue T; Uchida T; Sakuma M; Imoto Y; Ozeki Y; Ozaki Y; Hikichi Y; Node K
    J Am Coll Cardiol; 2004 Oct; 44(7):1408-14. PubMed ID: 15464320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Research and development of cilostazol: an antiplatelet agent].
    Nishi T; Kimura Y; Nakagawa K
    Yakugaku Zasshi; 2000 Dec; 120(12):1247-60. PubMed ID: 11193377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic activity of NSP-513, a novel selective phosphodiesterase 3 inhibitor, on femoral arterial thrombosis induced by physical stenosis and electrical current: comparison of antithrombotic and hemodynamic effects.
    Hirose H; Mashiko S; Kimura T; Ishida F; Mochizuki N; Nishibe T; Nishikibe M
    J Cardiovasc Pharmacol; 2000 Apr; 35(4):586-94. PubMed ID: 10774790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cilostazol, a novel cyclic AMP phosphodiesterase inhibitor, prevents reocclusion after coronary arterial thrombolysis with recombinant tissue-type plasminogen activator.
    Saitoh S; Saito T; Otake A; Owada T; Mitsugi M; Hashimoto H; Maruyama Y
    Arterioscler Thromb; 1993 Apr; 13(4):563-70. PubMed ID: 8385480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of shear stress-induced platelet aggregation by cilostazol, a specific inhibitor of cGMP-inhibited phosphodiesterase, in vitro and ex vivo.
    Minami N; Suzuki Y; Yamamoto M; Kihira H; Imai E; Wada H; Kimura Y; Ikeda Y; Shiku H; Nishikawa M
    Life Sci; 1997; 61(25):PL 383-9. PubMed ID: 9416770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a single local administration of cilostazol on neointimal formation in balloon-injured rat carotid artery.
    Ishizaka N; Taguchi J; Kimura Y; Ikari Y; Aizawa T; Togo M; Miki K; Kurokawa K; Ohno M
    Atherosclerosis; 1999 Jan; 142(1):41-6. PubMed ID: 9920504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cilostazol (pletal): a dual inhibitor of cyclic nucleotide phosphodiesterase type 3 and adenosine uptake.
    Liu Y; Shakur Y; Yoshitake M; Kambayashi Ji J
    Cardiovasc Drug Rev; 2001; 19(4):369-86. PubMed ID: 11830753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of anti-platelet aggregatory effects of aspirin, cilostazol and ramatroban on platelet-rich plasma and whole blood.
    Kariyazono H; Nakamura K; Arima J; Ayukawa O; Onimaru S; Masuda H; Iguro Y; Majima HJ; Sakata R; Yamada K
    Blood Coagul Fibrinolysis; 2004 Mar; 15(2):157-67. PubMed ID: 15091003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The phosphodiesterase 3 inhibitor cilostazol dilates large cerebral arteries in humans without affecting regional cerebral blood flow.
    Birk S; Kruuse C; Petersen KA; Jonassen O; Tfelt-Hansen P; Olesen J
    J Cereb Blood Flow Metab; 2004 Dec; 24(12):1352-8. PubMed ID: 15625409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cilostazol, a phosphodiesterase 3 inhibitor, protects mice against acute and late ischemic brain injuries.
    Ye YL; Shi WZ; Zhang WP; Wang ML; Zhou Y; Fang SH; Liu LY; Zhang Q; Yu YP; Wei EQ
    Eur J Pharmacol; 2007 Feb; 557(1):23-31. PubMed ID: 17161838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of anti-platelet aggregating activity of cilostazol with vascular endothelial cells.
    Igawa T; Tani T; Chijiwa T; Shiragiku T; Shimidzu S; Kawamura K; Kato S; Unemi F; Kimura Y
    Thromb Res; 1990 Feb; 57(4):617-23. PubMed ID: 2158154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cilostazol, an inhibitor of type 3 phosphodiesterase, produces endothelium-independent vasodilation in pressurized rabbit cerebral penetrating arterioles.
    Nakamura K; Ikomi F; Ohhashi T
    J Vasc Res; 2006; 43(1):86-94. PubMed ID: 16286783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelium-dependent relaxation by cilostazol, a phosphodiesteras III inhibitor, on rat thoracic aorta.
    Nakamura T; Houchi H; Minami A; Sakamoto S; Tsuchiya K; Niwa Y; Minakuchi K; Nakaya Y
    Life Sci; 2001 Aug; 69(15):1709-15. PubMed ID: 11665832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cilostazol in the management of vascular disease.
    Dalainas I
    Int Angiol; 2007 Mar; 26(1):1-7. PubMed ID: 17353881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of cilostazol, a cyclic AMP phosphodiesterase inhibitor, on pulmonary vascular tone].
    Shigemori K; Ishizaki T; Takahashi H; Sasaki F; Ameshima S; Ohnishi T; Sakai T; Nakai T; Miyabo S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Aug; 31(8):936-41. PubMed ID: 8230891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clopidogrel resistance and the effect of combination cilostazol in patients with ischemic stroke or carotid artery stenting using the VerifyNow P2Y12 Assay.
    Maruyama H; Takeda H; Dembo T; Nagoya H; Kato Y; Fukuoka T; Deguchi I; Horiuchi Y; Tanahashi N
    Intern Med; 2011; 50(7):695-8. PubMed ID: 21467700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory action of cilostazol, a phosphodiesterase III inhibitor, on catecholamine secretion from cultured bovine adrenal chromaffin cells.
    Azuma M; Houchi H; Mizuta M; Kinoshita M; Teraoka K; Minakuchi K
    J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S29-32. PubMed ID: 12688393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of cilostazol, a cyclic AMP phosphodiesterase inhibitor, on the proliferation of rat aortic smooth muscle cells in culture.
    Takahashi S; Oida K; Fujiwara R; Maeda H; Hayashi S; Takai H; Tamai T; Nakai T; Miyabo S
    J Cardiovasc Pharmacol; 1992 Dec; 20(6):900-6. PubMed ID: 1282592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A highly constrained cyclic (S,S)-CDC- peptide is a potent inhibitor of carotid artery thrombosis in rabbits.
    Roussa VD; Stathopoulou EM; Papamichael ND; Englezopoulos CV; Rousouli KI; Trypou P; Moussis V; Tellis CC; Katsouras CS; Tsikaris V; Tselepis AD; Michalis LK
    Platelets; 2011; 22(5):361-70. PubMed ID: 21158497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.